Charles Berkman

Charles Berkman

Direktör/Styrelseledamot på PFENEX INC.

Förmögenhet: 981 749 $ per 2026-06-30

57 år
Health Technology
Commercial Services
Consumer Services

Profil

Charles Stuart Berkman is Secretary, Director, Senior VP & General Counsel at Pelican, Inc. since 2020.
Holds positions as Secretary & Director at Ligand UK Group Ltd., Secretary & Vice President at Metabasis Therapeutics, Inc. since 2010, Secretary & Chief Legal Officer at OmniAb Operations, Inc. since 2022, and Secretary & Chief Legal Officer at OmniAb, Inc. since 2022.
Formerly Secretary & Director at Ligand UK Research Ltd. and Ligand UK Ltd. from 2018 to 2022.
Served as Secretary, Senior Vice President & General Counsel at Ligand Pharmaceuticals, Inc. from 2001 to 2022.
Worked as Attorney at Baker & McKenzie LLP (Illinois) from 2000 to 2001 and at Lyon & Lyon, Inc. from 1993 to 2000.
Completed undergraduate studies at The University of Texas at Austin and graduate studies at The University of Texas School of Law.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-04-23 399 085 ( 0,28 % ) 981 749 $ 2026-06-30

Aktiva positioner av Charles Berkman

FöretagPositionStart
PFENEX INC. Direktör/Styrelseledamot 2020-10-01
OMNIAB, INC. Generell Rådgivare 2022-03-01
Företagssekreterare 2010-01-29
Direktör/Styrelseledamot 2018-10-12
Generell Rådgivare 2022-03-01

Tidigare kända positioner av Charles Berkman

FöretagPositionSlut
Direktör/Styrelseledamot 2024-03-19
LIGAND PHARMACEUTICALS INCORPORATED Generell Rådgivare 2022-11-01
VERNALIS Direktör/Styrelseledamot 2022-11-01
Företagsledare/Principal 2001-11-01
░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Charles Berkmans erfarenhet

Charles Berkmans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

66

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

  1. Börsen
  2. Insiders
  3. Charles Berkman